Research Paper Volume 15, Issue 24 pp 14996—15024
ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network
Figure 6. Relationship between ATRX and target genes in GSE1. The relationship between ATRX and the target genes of AR (A), GATA2 (B) and GLI3 (C). (D) GSEA analysis of AR’s target genes.